Gary K. Barnette, PH.D.
Senior Vice President of Scientific and Regulatory Affairs
With more than 20 years of industry experience, Dr. K. Gary Barnette brings to Camargo a wealth of knowledge of FDA regulations. At Camargo, Barnette is responsible for propelling the growth of the company and establishing excellent customer service practices by utilizing his substantial experience within the drug development industry.
Most recently, Barnette served as vice president of clinical research and development strategy at GTx Inc. During his tenure at GTx Inc., his responsibilities included driving development of clinical strategy of all clinical programs and the scientific design and authorship of all clinical protocols and other clinical documents, including those for institutional review boards and ethics committees. Furthermore, Barnette was a member of joint drug development committees — with industry leaders such as Merck, Orion, Johnson & Johnson and Ipsen — that developed clinical and regulatory strategy and implemented corporate goals for the development of various products.
Before his position at GTx, Barnette served as the director of regulatory affairs for Solvay Pharmaceuticals and worked at the FDA Office of Clinical Pharmacology and Biopharmaceutics as a reviewer of more than 50 NDA and supplemental NDA submissions and more than 200 IND submissions. A published professional, Barnette’s work has been featured in the Journal of Cachexia, Sarcopenia and Muscle, Journal of Urology and Journal of Clinical Oncology.
Barnette received his Bachelor of Science with a biology and chemistry minor from Salem College and holds a Ph.D. in basic pharmaceutical sciences from West Virginia University, School of Pharmacy.